Oculus Innovative Sciences to Announce Additional Phase II Data and Data from Two Recent International Studies at DFCon 08 Mar 11, 2008
Oculus Innovative Sciences Schedules Conference Call Today to Discuss Positive Top-Line Phase II Data with Microcyn(R) Technology in Mildly Infected Diabetic Foot Ulcers Feb 27, 2008
Oculus Innovative Sciences Announces Positive Top-Line Phase II Data with Microcyn(R) Technology in Mildly Infected Diabetic Foot Ulcers Feb 27, 2008
Oculus Innovative Sciences to Present at the Roth Capital Partners 20th Annual OC Growth Stock Conference Feb 14, 2008
Oculus Innovative Sciences Announces Fiscal Third Quarter 2008 Quarterly Results and Clinical Update Feb 7, 2008
Oculus Innovative Sciences Announces Agreement with Animal Health International for North American Distribution of Microcyn(R)-Based Vetericyn(TM) Wound Spray Jan 29, 2008
Oculus Innovative Sciences Awarded Damages by Federal Court in Intellectual Property Rights Litigation Jan 24, 2008
Top-Line Data from Oculus Innovative Sciences' Phase II Trial to Be Presented at DFCon 08 (Diabetic Foot Global Conference) on March 14, 2008 Jan 22, 2008
